Metformina Sandoz

Metformin, the active ingredient in Metformina Sandoz, is a biguanide presented as a tablet for oral use. It improves glycemic control in adults with type 2 diabetes mellitus by reducing hepatic glucose output and increasing peripheral insulin sensitivity. The medication is indicated for long‑term management of hyperglycaemia and is commonly prescribed as part of a comprehensive diabetes care plan.

GNH USA supplies Metformina Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across EU and other markets.

Metformina Sandoz (metformin) is used in the management of disorders related to impaired glucose regulation. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels, helping achieve glycaemic targets.

Metformina Sandoz may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea - Metallic taste: transient alteration in taste perception - Loss of appetite: reduced desire to eat - Headache: mild to moderate intensity

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic disturbance - Severe hypoglycaemia: when combined with insulin or sulfonylureas - Hepatic failure: marked liver dysfunction - Allergic reaction: rash, pruritus, or angio‑edema

When prescribing Metformina Sandoz, clinicians should consider several safety aspects. - Renal function: assess eGFR before initiating and periodically monitor - Lactic acidosis risk: avoid in patients with significant hepatic impairment or hypoxia - Alcohol consumption: limit intake to reduce acidosis risk - Drug interactions: review concomitant medications for potential effects on metformin levels - Pregnancy and lactation: evaluate risk‑benefit; use only if clearly needed - Store at ambient temperature: keep in original container, protect from moisture and light

Metformina Sandoz can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute kidney injury, increasing lactic acidosis risk - Cimetidine: can raise metformin plasma concentrations - Alcohol binge: potentiates risk of lactic acidosis

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia - Diuretics (especially thiazides): can affect renal clearance of metformin - ACE inhibitors or ARBs: monitor renal function and electrolytes during combined therapy